NuCana Plc (NCNA)
2.25
+0.12
(+5.63%)
USD |
NASDAQ |
Apr 17, 16:00
2.27
+0.02
(+0.89%)
Pre-Market: 20:00
NuCana Research and Development Expense (Quarterly) : 2.309M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 4.187M |
| Bicycle Therapeutics Plc | 58.15M |
| Autolus Therapeutics Plc | 35.58M |
| DBV Technologies SA | 30.04M |